Impact of enrofloxacin on the human intestinal microbiota revealed by comparative molecular analysis

Anaerobe

Volumn 18, Issue 3, 2012, Pages 310-320

  Kim, Bong Soo ^a   Kim, Jong Nam ^a   Yoon, Seok Hwan ^b   Chun, Jongsik ^b   Cerniglia, Carl E ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b Seoul National University   (South Korea)

Author keywords

Denaturing gradient gel electrophoresis; In vitro culture system; Metatranscriptome; Pyrosequencing

Indexed keywords

ENROFLOXACIN; MESSENGER RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTEROIDETES; COMMUNITY STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FECES CULTURE; FIRMICUTES; GENE EXPRESSION; GENE FUNCTION; HUMAN; IN VITRO STUDY; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRINCIPAL COORDINATE ANALYSIS; PRIORITY JOURNAL; PROTEOBACTERIA; PYROSEQUENCING; RNA SEQUENCE; RNA TRANSCRIPTION; TRANSCRIPTOMICS;

ANTI-BACTERIAL AGENTS; BACTEROIDETES; CLUSTER ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DRUG RESISTANCE, BACTERIAL; FECES; FLUOROQUINOLONES; GENE EXPRESSION PROFILING; GENES, BACTERIAL; GRAM-POSITIVE BACTERIA; HUMANS; MALE; METAGENOME; MIDDLE AGED; PHYLOGENY; PROTEOBACTERIA; RNA, BACTERIAL; RNA, MESSENGER; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA;

BACTERIA (MICROORGANISMS); BACTEROIDETES; FIRMICUTES; PROTEOBACTERIA;

EID: 84862798113     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2012.01.003     Document Type: Article

References (49)

1. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008, 6:e280.
2. Larsen N., Vogensen F.K., van den Berg F.W.J., Nielsen D.S., Andreasen A.S., Pedersen B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010, 5:e9085.
3. Jakobsson H.E., Jernberg C., Andersson A.F., Sjolund-Karlsson M., Jansson J.K., Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010, 5:e9836.
4. Adamsson I., Nord C.E., Lundquist P., Sjostedt S., Edlund C. Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 1999, 44:629-640.
5. Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007, 1:56-66.
6. Sjolund M., Tano E., Blaser M.J., Andersson D.I., Engstrand L. Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin. Emerg Infect Dis 2005, 11:1389-1393.
7. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005, 102:11070-11075.
8. Tannock G.W. The search for disease-associated compositional shifts in bowel bacterial communities of humans. Trends Microbiol 2008, 16:488-495.
9. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
10. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455:1109-1113.
11. De Ruyck H., Daeseleire E., Grijspeerdt K., De Ridder H., Van Renterghem R., Huyghebaert G. Distribution and depletion of flubendazole and its metabolites in edible tissues of guinea fowl. Br Poult Sci 2004, 45:540-549.
12. Mortier L., Daeseleire E., Huyghebaert G., Grijspeerdt K., Van Peteghem C. Detection of residues of the coccidiostat diclazuril in poultry tissues by liquid chromatography-tandem mass spectrometry after withdrawal of medicated feed. J Agric Food Chem 2005, 53:905-911.
13. Reyes-Herrera I., Donoghue D.J. Antibiotic residues distribute uniformly in broiler chicken breast muscle tissue. J Food Prot 2008, 71:223-225.
14. Poroyko V., White J.R., Wang M., Donovan S., Alverdy J., Liu D.C., et al. Gut microbial gene expression in mother-fed and formula-fed piglets. PLoS One 2010, 5:e12459.
15. Pena A., Silva L.J.G., Pereira A., Meisel L., Lino C.M. Determination of fluoroquinolone residues in poultry muscle in Portugal. Anal Bioanal Chem 2010, 397:2615-2621.
16. Tian H. Determination of chloramphenicol, enrofloxacin and 29 pesticides residues in bovine milk by liquid chromatography-tandem mass spectrometry. Chemosphere 2011, 83:349-355.
17. Cerniglia C.E., Kotarski S. Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora. J Vet Pharmacol Ther 2005, 28:3-20.
18. Iovine N.M., Blaser M.J. Antimicrobial resistance in Campylobacter. Emerg Infect Dis 2004, 10:1346.
19. Idowu O.R., Peggins J.O., Cullison R., Bredow Jv Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacin. Res Vet Sci 2010, 89:230-235.
20. Reyes-Herrera I., Schneider M.J., Blore P.J., Donoghue D.J. The relationship between blood and muscle samples to monitor for residues of the antibiotic enrofloxacin in chickens. Poult Sci 2011, 90:481-485.
21. Stapleton K., Cawthraw S.A., Cooles S.W., Coldham N.G., La Ragione R.M., Newell D.G., et al. Selecting for development of fluoroquinolone resistance in a Campylobacter jejuni strain 81116 in chickens using various enrofloxacin treatment protocols. J Appl Microbiol 2010, 109:1132-1138.
22. Wang Y.-C., Chan J.P.-W., Yeh K.-S., Chang C.-C., Hsuan S.-L., Hsieh Y.-M., et al. Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates. Vet Microbiol 2010, 142:309-312.
23. Kaartinen L., Salonen M., Alli L., Pyorala S. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J Vet Pharmacol Ther 1995, 18:357-362.
24. Kung K., Riond J.L., Wanner M. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J Vet Pharmacol Ther 1993, 16:462-468.
25. Prescott J.F., Yielding K.M. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin, and norfloxacin. Can J Vet Res 1990, 54:195-197.
26. Carman R.J., Woodburn M.A. Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora. Regul Toxicol Pharmacol 2001, 33:276-284.
27. Chen T., Yuan J., Feng X., Wei H., Hua W. Effects of enrofloxacin on the human intestinal microbiota in vitro. Int J Antimicrob Agents 2011, 37:567-571.
28. Perrin-Guyomard A., Poul J.-M., Laurentie M., Sanders P., Fernandez A.H., Bartholomew M. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model. Regul Toxicol Pharmacol 2006, 45:66-78.
29. Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009, 10:57-63.
30. Frias-Lopez J., Shi Y., Tyson G.W., Coleman M.L., Schuster S.C., Chisholm S.W., et al. Microbial community gene expression in ocean surface waters. Proc Natl Acad Sci USA 2008, 105:3805-3810.
31. Kim B.-S., Kim J.N., Cerniglia C.E. In vitro culture conditions for maintaining a complex population of human gastrointestinal tract microbiota. J Biomed Biotechnol 2011, 10. 10.1155/2011/.
32. Ben Omar N., Ampe F. Microbial community dynamics during production of the Mexican fermented maize dough pozol. Appl Environ Microbiol 2000, 66:3664-3673.
33. Lopez I., Ruiz-Larrea F., Cocolin L., Orr E., Phister T., Marshall M., et al. Design and evaluation of PCR primers for analysis of bacterial populations in wine by denaturing gradient gel electrophoresis. Appl Environl Microbiol 2003, 69:6801-6807.
34. Chun J., Kim K.Y., Lee J.-H., Choi Y. The analysis of oral microbial communities of wild-type and toll-like receptor 2-deficient mice using a 454 GS FLX Titanium pyrosequencer. BMC Microbiol 2010, 10:101.
35. Chun J., Lee J.-H., Jung Y., Kim M., Kim S., Kim B.K., et al. EzTaxon: a web-based tool for the identification of prokaryotes based on 16S ribosomal RNA gene sequences. Int J Syst Evol Microbiol 2007, 57:2259-2261.
36. Schloss P.D., Westcott S.L., Ryabin T., Hall J.R., Hartmann M., Hollister E.B., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009, 75:7537-7541.
37. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009, 106:2365-2370.
38. Schloss P.D., Handelsman J. Status of the microbial census. Microbiol Mol Biol Rev 2004, 68:686-691.
39. Hamady M., Lozupone C., Knight R. Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J 2010, 4:17-27.
40. Meyer F., Paarmann D., D'Souza M., Olson R., Glass E.M., Kubal M., et al. The metagenomics RAST server - a public resource for the automatic phylogenetic and functional analysis of metagenomes. BMC Bioinform 2008, 9:386.
41. Marchler-Bauer A., Anderson J.B., DeWeese-Scott C., Fedorova N.D., Geer L.Y., He S., et al. CDD: a curated Entrez database of conserved domain alignments. Nucleic Acids Res 2003, 31:383-387.
42. Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I., Knight R. Bacterial community variation in human body habitats across space and time. Science 2009, 326:1694-1697.
43. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
44. Claesson M.J., Cusack S., O'Sullivan O., Greene-Diniz R., de Weerd H., Flannery E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2010, 108:4586-4591.
45. Andres M.T., Chung W.O., Roberts M.C., Fierro J.F. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother 1998, 42:3022-3023.
46. Boyanova L., Kolarov R., Gergova G., Dimitrova L., Mitov I. Trends in antibiotic resistance in Prevotella species from patients of the University Hospital of Maxillofacial Surgery. Anaerobe 2010, 16:489-492. Sofia, Bulgaria, in 2003-2009.
47. Flint H.J., Duncan S.H., Scott K.P., Louis P. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 2007, 9:1101-1111.
48. Belenguer A., Duncan S.H., Calder A.G., Holtrop G., Louis P., Lobley G.E., et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 2006, 72:3593-3599.
49. Price L.B., Liu C.M., Melendez J.H., Frankel Y.M., Engelthaler D., Aziz M., et al. Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS One 2009, 4:e6462.